Highlighted
Results for the Third Quarter and YTD September 2025
Oct 24, 2025
Medistim delivers another strong quarter, with solid growth and record sales year-to-date.
Medistim receives EU MDR certificates for MiraQ systems and TTFM probes
Oct 18, 2024
After years of preparation, Medistim has successfully obtained its first CE certificates under the latest EU Medical Device Regulation (EU MDR 2017/745).
Medistim is opening a direct sales office in Sweden
Oct 31, 2023
This move is part of the company's ongoing commitment to providing exceptional service to customers as well as fulfilling the company’s global growth strategy. The company is well positioned to continue its growth by further…
Medistim announces partnership with ROMA-Women Trial
Jun 5, 2023
Medistim is pleased to announce its partnership with ROMA-Women, a groundbreaking cardiac surgery trial that is specifically focused on women. Historically, cardiovascular research and treatment protocols have primarily focused on men, leaving women underrepresented in…
Medistim is opening a direct sales office in China
Apr 3, 2023
More than 60,000 coronary bypass procedures are performed in China annually and the number is expected to continue to grow high single digit in the years to come. Today, about 70% of these procedures are…
Medistim Expands Market Coverage in Canada by Going Direct
Mar 22, 2023
“We are excited to announce this strategic move that will strengthen our relationship with our customers in Canada and grow our business there,” – Medistim President and CEO Kari E. Krogstad
Capital Markets Day 2023
Feb 27, 2023
See the recording from Medistim's Capital Markets Day on March 21st where two international thought leaders, Professors John. D. Puskas and Pirkka Vikatmaa shared their insights on the future trends in Cardiac and Vascular Surgery…
